Journal article
Loss of HD-PTP function results in lipodystrophy, defective cellular signaling, and altered lipid homeostasis
Journal of cell science, Vol.137(18), jcs262032
09/15/2024
DOI: 10.1242/jcs.262032
PMCID: PMC11449442
PMID: 39155850
Abstract
His Domain Protein Tyrosine Phosphatase (HD-PTP) facilitates function of the endosomal sorting complexes required for transport (ESCRTs) during multivesicular body (MVB) formation. To uncover its role in physiological homeostasis, embryonic lethality caused by a complete lack of HD-PTP was bypassed through generation of hypomorphic mice expressing reduced protein, resulting in animals that are viable into adulthood. These mice exhibited marked lipodystrophy and decreased receptor-mediated signaling within white adipose tissue (WAT), involving multiple prominent pathways including RAS/MAPK, PI3K/AKT and RTKs such as EGFR. EGFR signaling was dissected in vitro to assess the nature of defective signaling, revealing decreased trans-autophosphorylation and downstream effector activation, despite normal EGF binding. This corresponds to decreased plasma membrane cholesterol and increased lysosomal cholesterol, likely resulting from defective endosomal maturation necessary for cholesterol trafficking and homeostasis. ESCRT components Vps4 and HRS have previously been implicated in cholesterol homeostasis, thus these findings expand knowledge on which ESCRT subunits are involved in cholesterol homeostasis and highlight a non-canonical role for HD-PTP in signal regulation and adipose tissue homeostasis.His Domain Protein Tyrosine Phosphatase (HD-PTP) facilitates function of the endosomal sorting complexes required for transport (ESCRTs) during multivesicular body (MVB) formation. To uncover its role in physiological homeostasis, embryonic lethality caused by a complete lack of HD-PTP was bypassed through generation of hypomorphic mice expressing reduced protein, resulting in animals that are viable into adulthood. These mice exhibited marked lipodystrophy and decreased receptor-mediated signaling within white adipose tissue (WAT), involving multiple prominent pathways including RAS/MAPK, PI3K/AKT and RTKs such as EGFR. EGFR signaling was dissected in vitro to assess the nature of defective signaling, revealing decreased trans-autophosphorylation and downstream effector activation, despite normal EGF binding. This corresponds to decreased plasma membrane cholesterol and increased lysosomal cholesterol, likely resulting from defective endosomal maturation necessary for cholesterol trafficking and homeostasis. ESCRT components Vps4 and HRS have previously been implicated in cholesterol homeostasis, thus these findings expand knowledge on which ESCRT subunits are involved in cholesterol homeostasis and highlight a non-canonical role for HD-PTP in signal regulation and adipose tissue homeostasis.
Details
- Title: Subtitle
- Loss of HD-PTP function results in lipodystrophy, defective cellular signaling, and altered lipid homeostasis
- Creators
- Destiny F Schultz - Mayo ClinicBrian A Davies - Mayo ClinicJohanna A Payne - Mayo ClinicCole P Martin - Mayo ClinicAnnabel Y Minard - University of IowaBennett G Childs - Mayo Clinic in FloridaCheng Zhang - Mayo ClinicKarthik B Jeganathan - Mayo Clinic in FloridaInes Sturmlechner - Mayo Clinic in FloridaThomas A White - Mayo Clinic in FloridaAlain de Bruin - University Medical Center GroningenLiesbeth Harkema - Utrecht UniversityHuiqin Chen - The University of Texas MD Anderson Cancer CenterMichael A Davies - The University of Texas MD Anderson Cancer CenterSarah Jachim - Mayo ClinicNathan K LeBrasseur - Mayo Clinic in FloridaRobert C Piper - University of IowaHu Li - Mayo ClinicDarren J Baker - Mayo ClinicJan van Deursen - Mayo ClinicDaniel D Billadeau - Mayo ClinicDavid J Katzmann - Mayo Clinic
- Resource Type
- Journal article
- Publication Details
- Journal of cell science, Vol.137(18), jcs262032
- DOI
- 10.1242/jcs.262032
- PMID
- 39155850
- PMCID
- PMC11449442
- NLM abbreviation
- J Cell Sci
- ISSN
- 1477-9137
- eISSN
- 1477-9137
- Publisher
- COMPANY BIOLOGISTS LTD
- Grant note
- Dr Miriam and Sheldon G. Adelson Medical Research Foundation: T32DK124190 American Cancer Society: P50CA221703
This work was funded by National Institutes of Health (NIH) (R01GM116826 awarded to D.J.K.) . D.F.S. is supported by the NIH (R25GM55252 and T32DK124190) . M.A.D. is supported by the Dr Miriam and Sheldon G. Adelson Medical Research Foundation, the AIM at Melanoma Foundation, the NIH (NCI; P50CA221703) , the American Cancer Society and the Melanoma Research Alliance, Cancer Fighters of Houston, the Anne and John Mendelsohn Chair for Cancer Research, and philanthropic contributions to the Melanoma Moon Shots Program of MD Anderson. Deposited in PMC for release after 12 months.
- Language
- English
- Electronic publication date
- 08/19/2024
- Date published
- 09/15/2024
- Academic Unit
- Molecular Physiology and Biophysics; Medicine Administration; Internal Medicine
- Record Identifier
- 9984699523202771
Metrics
11 Record Views